Novel insights in pharmacogenetics of drug response in Parkinson's disease

Pharmacogenomics. 2010 Feb;11(2):127-9. doi: 10.2217/pgs.09.175.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / metabolism
  • Antiparkinson Agents / therapeutic use*
  • Dopamine Agents / therapeutic use
  • Enzymes / genetics
  • Enzymes / metabolism
  • Genetic Variation
  • Humans
  • Neurotransmitter Agents / physiology
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / genetics*
  • Parkinson Disease / physiopathology
  • Pharmacogenetics*
  • Precision Medicine

Substances

  • Antiparkinson Agents
  • Dopamine Agents
  • Enzymes
  • Neurotransmitter Agents